// App-Quantinova.ai

2918 : Enhanced Outcome Prediction in Early Stage Classical Hodgkin Lymphoma Using Pre-Treatment Biomarkers and Interim PET (BioPET); A Sub-Analysis of the UK NCRI RAPID Trial

Researchers

Presenter

  • Kim M Linton

Principal Investigators

  • Joanna M Oladipo

  • Nicholas Counsell

  • Janet Taylor

  • Cathy Burton

  • Rachel Oakley

  • Joanna Williams

  • Sally F Barrington

  • Richard Byers

  • Timothy Illidge

  • John A. Radford

Medical Centers

  • The Christie NHS Foundation Trust, Manchester Cancer Research Centre and Manchester Academic Health Science Centre, Manchester, United Kingdom

  • University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

  • Cancer Research UK and UCL Cancer Trials Centre/UCL Cancer Institute, London, United Kingdom

  • Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds, UK

  • Guy's and St. Thomas' Hospital and Kings College, London, Kent, United Kingdom

  • University of Manchester, Manchester, United Kingdom

  • The Christie NHS Foundation Trust, Manchester Cancer Research Centre and Manchester Academic Health Science Centre, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • NCT00943423

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved